Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison. [electronic resource]
Producer: 20130604Description: 381-95 p. digitalISSN:- 1179-1896
- Adolescent
- Adrenergic Uptake Inhibitors -- economics
- Adrenergic alpha-2 Receptor Agonists -- economics
- Atomoxetine Hydrochloride
- Attention Deficit Disorder with Hyperactivity -- drug therapy
- Child
- Cost-Benefit Analysis
- Delayed-Action Preparations
- Female
- Guanfacine -- economics
- Humans
- Male
- Markov Chains
- Propylamines -- economics
- Quality-Adjusted Life Years
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.